✦ LIBER ✦

Intraductal trastuzumab treatment may be effective in the management of ductal carcinoma in situ of the breast with HER-2 overexpression

✍ Scribed by Kadri Altundag; Mehmet E Tezcan; Mehmet Ozen; Fatih Karaahmet; Nilufer Bulut

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trastuzumab (Herceptin) in the treatment

✍ Joel M. Salazar Cavazos; Juan Francisco González Guerrero; William O. Brito Vill 📂 Article 📅 2001 🏛 Springer Milan 🌐 Spanish ⚖ 100 KB

Pathobiological considerations relating

✍ Dr. Edwin R. Fisher 📂 Article 📅 1997 🏛 American Cancer Society 🌐 English ⚖ 675 KB

Advances in the Adjuvant Treatment of HE

✍ Chris Schwab; Joyce A. O'Shaughnessy 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 467 KB

Novel Clinical Trial Designs for Treatme

✍ Ricardo J. Gonzalez; Aman U. Buzdar; W. Fraser Symmans; Tina W. Yen; Kristine R. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 521 KB

Biologic and immunologic effects of preo

✍ Henry M. Kuerer; Aman U. Buzdar; Elizabeth A. Mittendorf; Francisco J. Esteva; A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB

Biologic and Immunologic Effects of Preo

✍ Julian, T.B.; Cobleigh, M.A.; Siziopikou, K.P. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB